Prognostic Significance of CHIP and RIPK3 in Non-Small Cell Lung Cancer

Jisup Kim1, Joon-Yong Chung2, Young Soo Park1

  • 1Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea.

Cancers
|June 12, 2020
PubMed

Insights

In non-small cell lung cancer (NSCLC), higher expression of CHIP correlates with longer survival, while higher RIPK3 expression is linked to shorter survival. These findings suggest CHIP and RIPK3 have opposing prognostic values in NSCLC patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Necroptosis, regulated by RIPK3, has a complex role in tumor progression.
  • CHIP, an E3 ubiquitin ligase, modulates necroptosis by targeting RIPK3 for degradation.

Purpose of the Study:

  • To investigate the prognostic significance of Receptor-Interacting Protein Kinase 3 (RIPK3) and Carboxyl Terminus of Hsp70-Interacting Protein (CHIP) expression in non-small cell lung cancer (NSCLC).

Main Methods:

  • Analysis of RIPK3 and CHIP expression levels in 404 NSCLC patients.
  • Correlation of expression levels with overall survival (OS) and disease-free survival (DFS).
  • Multivariate analysis to determine independent prognostic factors.

Main Results:

  • CHIP expression was positively correlated with longer OS, while RIPK3 expression was associated with shorter OS.
  • RIPK3 positivity suggested potential radioresistance in NSCLC patients receiving adjuvant radiotherapy.
  • CHIP expression emerged as an independent favorable prognostic factor in multivariate analysis.

Conclusions:

  • CHIP expression is a favorable prognostic indicator in NSCLC.
  • RIPK3 expression is an adverse prognostic indicator in NSCLC.
  • The opposing roles of CHIP and RIPK3 highlight their significance in NSCLC prognosis and potential therapeutic targeting.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K